Table 4: The cytokine levels of subjects (mean (SD)).

RASLET1DT1DNT2DT2DNHTNHT

IL-6 (ng/L)control2.31 (0.63)2.28 (0.71)2.39 (0.69)2.25 (0.67)2.01 (0.58)1.97 (0.64)2.33 (0.59)2.18 (0.61)
patients 5.02* (1.41)4.38* (1.64)2.47 (0.96)3.05* (1.53)2.78* (0.88)2.85* (0.93)2.58 (1.22)2.35 (0.97)

IL-17 (ng/L)control1.24 (0.21)1.26 (0.29)1.36 (0.31)1.38 (0.27)1.25 (0.33)1.33 (0.26)1.39 (0.40)1.28 (0.35)
patients 1.96* (0.90)2.13* (0.75)1.55 (0.76)1.97* (0.65)1.41 (0.57)1.48 (0.73)1.27 (0.70)1.35 (0.55)

TNF-α (ng/L)control12.37 (2.45)11.97 (3.69)12.39 (3.21)13.17 (3.39)12.02 (4.13)13.39 (3.64)12.47 (3.68)12.63 (4.36)
patients 14.65 (6.34)16.97* (6.93)13.23 (5.61)14.37 (8.35)15.23* (4.32)16.37* (6.55)11.95 (4.37)12.96 (3.37)

IFN-γ (ng/L)control11.0112.2511.6912.6411.6410.8911.3912.43
patients 16.38* (6.36)14.99* (4.08)12.06* (4.11)14.15* (5.62)12.03 (4.21) 11.59 (3.03)12.78 (4.32)13.36 (5.69)

*There were significant differences between patients and control (P < 0.05).
HTN: hypertensive nephropathy; HT: heart failure.